Pharmaceutical manufacturing has become a strategic sector across the Gulf, driven by health security priorities, local content policy, and the ambition to reduce dependence on imported medicines. It is also among the most demanding and rewarding specialisations for control systems engineers, because nothing you build goes into production until it has been formally proven to work.
The Gulf Pharmaceutical Landscape
Julphar, Gulf Pharmaceutical Industries, operates a large manufacturing complex in Ras Al Khaimah and is one of the region's longest-established pharmaceutical manufacturers, producing a broad range of formulations. Hikma Pharmaceuticals, headquartered in Amman with substantial manufacturing in Saudi Arabia and internationally, is one of the largest generics producers serving the Middle East and North America. SPIMACO operates from Al Qassim in Saudi Arabia, and Jamjoom Pharma, Tabuk Pharmaceuticals, and Sudair Pharma add further Saudi capacity.
In the UAE, Neopharma in ICAD Abu Dhabi and Globalpharma in Dubai represent domestic formulation capacity, and Dubai Science Park and KEZAD have both been positioned to attract life sciences manufacturing. The COVID-19 period accelerated regional interest in domestic fill-finish and vaccine capability, and several investments followed.
Automation in Pharmaceutical Manufacturing
Pharmaceutical automation must comply with stringent regulatory requirements. In the UAE the Ministry of Health and Prevention regulates manufacture and registration; in Saudi Arabia it is the Saudi Food and Drug Authority; and the GCC centralised registration procedure applies across member states. Manufacturers exporting to Europe or the United States must additionally satisfy EMA or FDA inspection. Every automated system must be validated to demonstrate it consistently produces product meeting predetermined specifications.
Key automation applications include:
- Batch processing: Controlled mixing, granulation, drying, and coating following ISA-88 batch control principles
- Filling and packaging: High-speed aseptic filling for injectables and automated packaging with serialisation and track-and-trace
- Environmental monitoring: Clean room pressure cascades, temperature, and humidity control to GMP standards, which is a heavier engineering problem in Gulf ambient conditions
- Weighing and dispensing: Precise raw material dispensing with electronic batch records
- Water systems: Purified water and water for injection generation, storage, and distribution, with continuous conductivity and TOC monitoring
Validation and GAMP 5
Validation is what distinguishes pharmaceutical automation from every other industry. Every automated system goes through a rigorous validation lifecycle documented in accordance with GAMP 5 (Good Automated Manufacturing Practice). This includes user requirement specifications, functional specifications, design specifications, and testing protocols (IQ, OQ, PQ).
Automation engineers in pharma must accept that every line of PLC code, every HMI screen, and every alarm setpoint must be documented, tested, and approved before production use. Changes to validated systems require formal change control. Data integrity expectations, commonly summarised as ALCOA+, apply directly to how you design audit trails, user access, and electronic records. This documentation-heavy approach adds complexity but is the entire point: it protects patients.
DCS vs PLC in Pharma
While many facilities use PLCs, larger sterile and API operations often rely on Distributed Control Systems from vendors such as Emerson (DeltaV), Honeywell (Experion), and ABB (800xA). DCS platforms offer integrated batch control, historian, and alarm management capabilities that align well with pharmaceutical requirements.
PLCs remain common in packaging, material handling, HVAC, and utility systems within pharmaceutical facilities. Engineers who understand both PLC and DCS platforms, and who can talk credibly about qualification, are particularly valuable in the regional market where validated-systems experience is genuinely scarce.
Career Opportunities and Salaries
Pharmaceutical automation roles include validation engineer, CSV specialist, automation engineer, controls engineer, MES specialist, and SCADA engineer. The sector pays well relative to general manufacturing because the specialist knowledge is hard to replace.
Indicative monthly ranges from public job-market data put entry-level validation and automation engineers in the region at roughly AED 8,000 to 14,000, experienced automation and CSV engineers at around AED 15,000 to 25,000, and senior validation leads and automation architects at roughly AED 26,000 to 40,000 and above. Ranges vary considerably between UAE, Saudi, and Jordanian operations and by employer package structure.
Future Trends
Regional pharmaceutical manufacturing is investing in serialisation and track-and-trace to meet national medicine tracking requirements, in electronic batch records to replace paper, and in MES integration between plant floor and enterprise systems. Continuous manufacturing and process analytical technology are beginning to appear on new lines. Biologics and fill-finish capability is a stated ambition in both the UAE and Saudi Arabia, and that would create demand for automation engineers with bioprocessing experience, currently one of the thinnest skill pools in the region.